Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,209
Total Claims
$1.2M
Drug Cost
457
Beneficiaries
$2,517
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
+78%
Cost per patient vs peers
$2,517 vs $1,411 avg
+37%
Brand preference vs peers
14.5% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
39
Opioid Claims
$1,141
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,922 claims · $748K
Generic: 17,178 claims · $395K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 569 | $157K |
| Daptomycin | 24 | $59K |
| Linaclotide | 106 | $57K |
| Lipase/Protease/Amylase | 74 | $41K |
| Pimavanserin Tartrate | 17 | $40K |
| Sitagliptin Phosphate | 136 | $37K |
| Enzalutamide | 11 | $37K |
| Insulin Aspart | 160 | $22K |
| Rivaroxaban | 74 | $20K |
| Dextromethorphan Hbr/Quinidine | 27 | $20K |
| Carbidopa/Levodopa | 36 | $19K |
| Sodium Zirconium Cyclosilicate | 59 | $18K |
| Linagliptin | 65 | $17K |
| Tenofovir Alafenamide | 12 | $16K |
| Dapagliflozin Propanediol | 54 | $15K |
Prescribing Profile
Patient Profile
81
Avg Age
60%
Female
2.74
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data